These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 15161353)
1. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Zhang Y; Jung M; Dritschilo A; Jung M Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353 [TBL] [Abstract][Full Text] [Related]
2. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. Zhang F; Zhang T; Teng ZH; Zhang R; Wang JB; Mei QB Cancer Biol Ther; 2009 May; 8(9):823-31. PubMed ID: 19270532 [TBL] [Abstract][Full Text] [Related]
6. Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci. Munshi A; Tanaka T; Hobbs ML; Tucker SL; Richon VM; Meyn RE Mol Cancer Ther; 2006 Aug; 5(8):1967-74. PubMed ID: 16928817 [TBL] [Abstract][Full Text] [Related]
7. A systematic assessment of radiation dose enhancement by 5-Aza-2'-deoxycytidine and histone deacetylase inhibitors in head-and-neck squamous cell carcinoma. De Schutter H; Kimpe M; Isebaert S; Nuyts S Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):904-12. PubMed ID: 19215824 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition. Blattmann C; Oertel S; Ehemann V; Thiemann M; Huber PE; Bischof M; Witt O; Deubzer HE; Kulozik AE; Debus J; Weber KJ Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):237-45. PubMed ID: 20646843 [TBL] [Abstract][Full Text] [Related]
9. Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation. Kuribayashi T; Ohara M; Sora S; Kubota N Int J Mol Med; 2010 Jan; 25(1):25-9. PubMed ID: 19956898 [TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331 [TBL] [Abstract][Full Text] [Related]
11. The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X. Karagiannis TC; Harikrishnan KN; El-Osta A Cancer Biol Ther; 2005 Jul; 4(7):787-93. PubMed ID: 16082178 [TBL] [Abstract][Full Text] [Related]
13. Rational design and development of radiation-sensitizing histone deacetylase inhibitors. Jung M; Kozikowski A; Dritschilo A Chem Biodivers; 2005 Nov; 2(11):1452-61. PubMed ID: 17191946 [TBL] [Abstract][Full Text] [Related]
14. Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents. Xue K; Gu JJ; Zhang Q; Mavis C; Hernandez-Ilizaliturri FJ; Czuczman MS; Guo Y J Cancer Res Clin Oncol; 2016 Feb; 142(2):379-87. PubMed ID: 26314218 [TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation. Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861 [TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitor-mediated radiosensitization of human cancer cells: class differences and the potential influence of p53. Kim IA; Shin JH; Kim IH; Kim JH; Kim JS; Wu HG; Chie EK; Ha SW; Park CI; Kao GD Clin Cancer Res; 2006 Feb; 12(3 Pt 1):940-9. PubMed ID: 16467109 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells. Moertl S; Payer S; Kell R; Winkler K; Anastasov N; Atkinson MJ Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269745 [TBL] [Abstract][Full Text] [Related]
18. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT. Bruzzese F; Leone A; Rocco M; Carbone C; Piro G; Caraglia M; Di Gennaro E; Budillon A J Cell Physiol; 2011 Sep; 226(9):2378-90. PubMed ID: 21660961 [TBL] [Abstract][Full Text] [Related]
20. The effects of SAHA on radiosensitivity in pancreatic cancer cells by inducing apoptosis and targeting RAD51. Wu Z; Jing S; Li Y; Gao Y; Yu S; Li Z; Zhao Y; Piao J; Ma S; Chen X Biomed Pharmacother; 2017 May; 89():705-710. PubMed ID: 28267674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]